Tags:BioTechPharmacyProduct
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting a class of pathological age associated compounds termed Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically position to develop therapeutics across multiple indications.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 17.03.2022 | Seed | $8.4M | - | finsmes.co... |
Mentions in press and media 2
